According to the latest report by IMARC Group, titled “Nuclear Medicine Equipment Market: Global Industry Trends, Share, Size, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the nuclear medicine equipment market growth. The global nuclear medicine equipment market size reached US$ 2.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4 Billion by 2027, exhibiting at a CAGR of 6.8% during 2022-2027.
Nuclear medicine equipment refer to medical devices that utilize radioactive materials or radionuclides to generate anatomical images and record the progression of diseases. Radionuclides represent the compounded cleaning molecules with excessive energy utilized for manufacturing radiopharmaceuticals. Nuclear medicine equipment are used for examining various biological processes, such as tissue blood flow, functioning of cell receptors, metabolism, neurotransmitter activity, and apoptosis. In addition, they utilize single-photon emission-computed tomography (SPECT) imaging technologies and specialized gamma cameras for detecting movement disorders and several types of dementia. As a result, nuclear medicine equipment find widespread applications in the treatment of gastrointestinal, endocrine, oncological, cardiovascular, and neurological disorders across the globe.
Request for a free sample copy of this report: https://www.imarcgroup.com/nuclear-medicine-equipment-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Market Trends:
The escalating prevalence of chronic medical ailments and the rising geriatric population that is more prone to age-related and associated diseases are among the primary factors driving the nuclear medicine equipment market. Besides this, elevating requirement for personalized medicines in patients and healthcare professionals is further augmenting the market growth. Moreover, various technological advancements, including the development of data-integrated imaging systems and radiotracers that enable the reconstruction and processing of computer-assisted images and accurate recognition of medical conditions to compare diagnostic scans and monitor the progression of a disease, are also catalyzing the global market. Apart from this, healthcare institutions are shifting from standalone to hybrid imaging techniques for generating precise and high-resolution images, which are acting as significant growth-inducing factors. Furthermore, the extensive research and development (R&D) activities in the field of biotechnology and the increasing improvements in the medical infrastructure, especially in the developing economies, are anticipated to propel the nuclear medicine equipment market over the forecasted period.
Breakup by Product:
Single-Photon Emission Computed Tomography
Standalone
Hybrid
Positron Emission Tomography
Standalone
Hybrid
Planar Scintigraphy
Breakup by Application:
Neurology
Oncology
Cardiology
Others
Breakup by End User:
Hospitals
Imaging Centers
Academic and Research Institutes
Others
Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/nuclear-medicine-equipment-market
Competitive Landscape with Key Player:
Biodex Medical Systems Inc. (Mirion Technologies Inc.)
Cardinal Health Inc
CMR Naviscan Corporation
DD-Diagnostic A/S
Digirad Corporation
General Electric Company
Koninklijke Philips N.V
Mediso Ltd
Neusoft Corporation
Siemens AG
SurgicEye GmbH
Toshiba Corporation
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Related Reports:
Latin America Dry Eye Syndrome Market Report: https://www.imarcgroup.com/latin-america-dry-eye-syndrome-market
Behavioral Rehabilitation Market Report: https://www.imarcgroup.com/behavioral-rehabilitation-market
Protein Detection & Quantification Market Report: https://www.imarcgroup.com/protein-detection-quantification-market
Aerosol Delivery Devices Market Report: https://www.imarcgroup.com/aerosol-delivery-devices-market
Onychomycosis Treatment Market Report: https://www.imarcgroup.com/onychomycosis-treatment-market
Lateral Flow Assay Market Report: https://www.imarcgroup.com/lateral-flow-assay-market
Tissue Banking Market Report: https://www.imarcgroup.com/tissue-banking-market
Drug Device Combination Products Market Report: https://www.imarcgroup.com/drug-device-combination-products-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800